Biological Trace Element Research

, Volume 151, Issue 2, pp 247–255 | Cite as

Toxicity Evaluation of Chromium Picolinate Nanoparticles In Vivo and In Vitro in Rat

Article

Abstract

The toxicity of nanoCrpic is still not understood and needs further investigation. Thus, this study investigated the effect of chromium picolinate nanoparticles (nanoCrpic) on the toxicity in vivo and in vitro in rat. In the in vivo study, 36 rats (Wistar, 8-week-old) were randomly divided into the control group (fed basal diet), the low-dose (300 ppb, μg/kg), and high-dose (1,000 ppb) nanoCrpic groups. The trial was conducted for 2 months; at the final stage of the trial, the rats were sacrificed, liver and kidney were examined, and samples of tissues were taken for histological examination. Hepatocytes isolated from 10-week-old Wistar male rats were used for in vitro study to examine the degree of DNA damage following exposure to 0 and 0.294 mM of H2O2 for 30 min. Incubation medium was supplemented with 0 (control), 100, and 300 ppb nanoCrpic. In vivo study indicated that no lesions of liver or kidney were detected in 300 and 1,000 ppb nanoCrpic fed rats. The in vitro study evaluated DNA damage according to the percentage and distance of the fragments migration and revealed that there was insignificant difference between the nanoCrpic and control groups (p > 0.05). This study indicated that nanoCrpic at 300–1,000 ppb in vivo and at 100–300 ppb in vitro showed no signs of toxicity to rats.

Keywords

Nanoparticles Chromium picolinate Hepatocytes Toxicity Rats 

References

  1. 1.
    Evans GW, Bowman TD (1992) Chromium picolinate increases membrane fluidity and rate of insulin internalization. J Inorg Biochem 46:243–250PubMedCrossRefGoogle Scholar
  2. 2.
    Lien TF, Chen SY, Wu CP, Chen CL, Hu CY (1996) Effects of chromium picolinate and chromium chloride on growth performance and serum traits of growing-finishing swine. Proceeding of Western Section, Am Society Anim Sci 47:150–153Google Scholar
  3. 3.
    Lien TF, Chen SY, Shiau SP, Froman DP, Hu CY (1996) Chromium picolinate reduces laying hen serum and egg yolk cholesterol. Prof Anim Scient 12:77–80Google Scholar
  4. 4.
    Lien TF, Wu CP, Lin PH, Wang BJ, Lu JJ, Shiao TY (1998) Effect of different protein and limiting amino acid levels coupled with a supplement of chromium picolinate on lipid metabolism and carcass characteristics of pigs. Anim Sci 67:601–607CrossRefGoogle Scholar
  5. 5.
    Lien TF, Horng YM, Yang KH (1999) Growth performance, serum characteristics, carcass traits and lipid metabolism of broilers as affected by supplement of chromium picolinate. Br Poult Sci 40:357–363PubMedCrossRefGoogle Scholar
  6. 6.
    Lien TF, Wu CP, Wang BJ, Shiao MS, Shiao TY, Lin BH, Hu CY (2001) Effect of supplemental levels of chromium picolinate on the growth performance, serum traits, carcass characteristics and lipid metabolism of growing-finishing pigs. Anim Sci 72:289–296Google Scholar
  7. 7.
    Okada S, Tsukada H, Ohba H (1984) Enhancement of nucleo RNA synthesis by chromium(III) in regenerating rat liver. J Inorg Biochem 21:113–119PubMedCrossRefGoogle Scholar
  8. 8.
    Ohba H, Suzuki Y, Ohba H (1986) Enhancement of ribonucleic acid synthesis by chromium(III)-bound chromatin. J Inorg Biochem 27:179–188PubMedCrossRefGoogle Scholar
  9. 9.
    McCarty MF (1991) The case for supplemental chromium and a survey of clinical studies with chromium picolinate. J Apply Nutr 43:58–66Google Scholar
  10. 10.
    Page TG, Southern LL, Ward TL, Thompson JrTL (1993) Effect of chromium picolinate on growth and serum and carcass traits of growing-finishing pigs. J Anim Sci 71:656–662PubMedGoogle Scholar
  11. 11.
    Simonoff M, Llabador Y, Hamon C, Peers AM, Simonoff GN (1984) Low plasma chromium in patients with coronary artery and heart diseases. Biol Trace Elem Res 6:431–439CrossRefGoogle Scholar
  12. 12.
    Anderson RA, Bryden NA, Polansky MM (1997) Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr 16:273–279PubMedGoogle Scholar
  13. 13.
    Bagchi D, Sidney J, Downs BW, Bagchi M, Preuss HG (2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180:5–22PubMedCrossRefGoogle Scholar
  14. 14.
    Bagchi D, Bagchi M, Balmoori J, Ye X, Stohs SJ (1997) Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Res Commun Mol Pathol Pharmacol 97:335–346PubMedGoogle Scholar
  15. 15.
    Preuss HG, Grojec PL, Lieberman S, Anderson RA (1997) Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol 47:325–330PubMedGoogle Scholar
  16. 16.
    Danielsson BRG, Hassoun E, Dencker L (1982) Embryo toxicity of chromium: distribution in pregnant mice and effects on embryonic cells in vitro. Arch Toxicol 51:233–245Google Scholar
  17. 17.
    Hepburn DDD, Vincent JB (2002) In vitro distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chem Res Toxicol 15:93–100PubMedCrossRefGoogle Scholar
  18. 18.
    Stearns DM, Wise JPS, Patierno SR, Wetterhahn KE (1995) Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 9:1643–1648PubMedGoogle Scholar
  19. 19.
    Speetjens JK, Collins RA, Vincent JB, Woski SA (1999) The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol 12:483–487PubMedCrossRefGoogle Scholar
  20. 20.
    Hepburn DDD, Vincent JB (2003) Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem 94:86–93PubMedCrossRefGoogle Scholar
  21. 21.
    Vincent JB (2001) The bioinorganic chemistry of chromium (III). Polyhedron 20:1–26CrossRefGoogle Scholar
  22. 22.
    Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW (2011) Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92–100PubMedCrossRefGoogle Scholar
  23. 23.
    Florence AT, Hillery AM, Hussain N, Jani PU (1995) Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Controll Release 36:39–46CrossRefGoogle Scholar
  24. 24.
    Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microparticles in caco-2 cell is size dependent. Pharm Res 14:1568–1573PubMedCrossRefGoogle Scholar
  25. 25.
    Gonzales-Equia A, Fu CM, Lu FY, Lien TF (2009) Effects of nanocopper on copper availability and nutrients digestibility, growth performance and serum traits of piglets. Livest Sci 126:122–129CrossRefGoogle Scholar
  26. 26.
    Lien TF, Yeh HS, Lu FY, Fu CM (2009) Nanoparticles of chromium picolinate enhance chromium digestibility and absorption. J Sci Food Agric 89:1164–1167CrossRefGoogle Scholar
  27. 27.
    Karlsson HL, Gustafsson J, Cronholm P, Möller L (2009) Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size. Toxicol Lett 188:112–118PubMedCrossRefGoogle Scholar
  28. 28.
    FASS (1999) Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. Federation of Animal Science Societies.Google Scholar
  29. 29.
    Andrei L, Kindzelskii R, Howard RP (1999) Utrasensitive detection of hydrogen peroxide-mediated DNA damage after alkaline single cell gel electrophoresis using occultation microscopy and TUNEL labeling. Mutat Res 426:11–22CrossRefGoogle Scholar
  30. 30.
    Moldeus P, Hogberg J, Orrenius S (1978) Isolation and use of liver cell. In “Methods in enzymology”, Academic Press. New York Vol 52:60–71Google Scholar
  31. 31.
    Lowry OH, Rosebrough NJ, Farr L, Randall J (1951) Protein measuem with Folin-phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  32. 32.
    Statistical Analysis System Institute. (1998) SAS/STAT User’s guide, Version 6.06, 4th ed, Cary, NC.Google Scholar
  33. 33.
    Schwartz K, Mertz W (1959) Chromium III and the glucose tolerance factor. Arch Biochem Biophy 85:292–295CrossRefGoogle Scholar
  34. 34.
    Asharani PV, Low KMG, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–290PubMedCrossRefGoogle Scholar
  35. 35.
    Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen-Dechent W (2009) Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5:2067–2076PubMedCrossRefGoogle Scholar
  36. 36.
    Yang H, Liu C, Yang D, Zhang H, Xi Z (2009) Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Apply Toxicol 29:69–78CrossRefGoogle Scholar
  37. 37.
    Ahamed M, Siddiqui MA, Akhtar MJ, Ahmad I, Pant AB, Alhadlaq HA (2010) Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem Biophys Res Commun 396:578–583PubMedCrossRefGoogle Scholar
  38. 38.
    Arora S, Jain J, Rajwade JM, Paknikar KM (2008) Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 179:93–100PubMedCrossRefGoogle Scholar
  39. 39.
    Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY (2009) Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 23:1076–1084PubMedCrossRefGoogle Scholar
  40. 40.
    Foldbjerg R, Dang DA, Autrup H (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–750PubMedCrossRefGoogle Scholar
  41. 41.
    Hsiao IL, Huang YJ (2011) Titanium oxide shell coatings decrease the cytotoxicity of ZnO nanoparticles. Chem Res Toxicol 24:303–313PubMedCrossRefGoogle Scholar
  42. 42.
    Kawata K, Osawa M, Okabe S (2009) In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046–6051PubMedCrossRefGoogle Scholar
  43. 43.
    Tiwari DK, Jin T, Behari J (2011) Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Tocicol Mech Methods 21:13–24CrossRefGoogle Scholar
  44. 44.
    Hepburn DDD, Burney JM, Woski SA, Vincent JB (2003) The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo. Polyhedron 22:455–463CrossRefGoogle Scholar
  45. 45.
    Vincent JB (2000) The biochemistry of chromium. J Nutr 130:715–718PubMedGoogle Scholar
  46. 46.
    Rhodes MC, Hebert CD, Herbert RA, Morinello EJ, Roycroft JH, Travlos GS, Abdo KM (2005) Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem Toxicol 43:21–29PubMedCrossRefGoogle Scholar
  47. 47.
    Komorowski JR, Greenberg D, Juturu V (2008) Chromium picolinate does not produce chromosome damage. Toxicol In Vitro 22:819–826PubMedCrossRefGoogle Scholar
  48. 48.
    Gudi R, Slesinski RS, Clarke JJ, San RHC (2005) Chromium picolinate does not produce chromosome damage in CHO cells. Mutat Res 587:140–146PubMedCrossRefGoogle Scholar
  49. 49.
    Hininger I, Benaraba R, Osman M, Faure H, Roussel AM, Anderson RA (2007) Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes. Free Radic Biol Med 42:1759–1765PubMedCrossRefGoogle Scholar
  50. 50.
    Anderson MA, Grawe KVP, Karlsson OM, Abramsson-Zetterberg LAG, Hellman BE (2007) Evaluation of potential genotoxicity of chromium picolinate in mammalian cell in vivo and in vitro. Food Chem Toxicol 45:1097–1106CrossRefGoogle Scholar
  51. 51.
    Council NR (1980) Mineral tolerances of domestic animals. National Academy Press, Washington, D. CGoogle Scholar
  52. 52.
    Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A (2001) Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20:212–218PubMedGoogle Scholar
  53. 53.
    Cheng HH, Lai MH, Hou WC, Huang CL (2004) Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem 52:1385–1389PubMedCrossRefGoogle Scholar
  54. 54.
    Ohr LM (2005) Nutraceuticals and functional foods. Food Technol 59:53–55Google Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Animal ScienceNational Chiayi UniversityLuh Liau Li, ChiayiRepublic of China

Personalised recommendations